Ahrens Investment Partners LLC - EXELIXIS INC ownership

EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ahrens Investment Partners LLC ownership history of EXELIXIS INC
ValueSharesWeighting
Q1 2023$213,510
+21.0%
11,0000.0%0.11%
+32.5%
Q4 2022$176,440
+2.6%
11,0000.0%0.08%
-12.1%
Q3 2022$172,000
-24.9%
11,0000.0%0.09%
-9.9%
Q2 2022$229,000
-8.0%
11,0000.0%0.10%
+27.8%
Q1 2022$249,000
+23.9%
11,0000.0%0.08%
-11.2%
Q4 2021$201,000
-12.6%
11,000
+0.9%
0.09%
-19.1%
Q3 2021$230,000
+15.6%
10,9000.0%0.11%
+19.6%
Q2 2021$199,000
-19.1%
10,9000.0%0.09%
-25.8%
Q1 2021$246,000
+12.3%
10,9000.0%0.12%
+6.0%
Q4 2020$219,000
-18.0%
10,9000.0%0.12%
-34.3%
Q3 2020$267,000
+3.1%
10,9000.0%0.18%
+12.7%
Q2 2020$259,000
+37.8%
10,9000.0%0.16%
+17.0%
Q1 2020$188,000
-2.1%
10,9000.0%0.14%
+68.8%
Q4 2019$192,000
-78.4%
10,900
-69.7%
0.08%
-79.1%
Q2 2017$887,000
+14.3%
36,000
+0.6%
0.38%
+2.4%
Q1 2017$776,000
+80.0%
35,800
+23.9%
0.37%
+65.0%
Q4 2016$431,00028,9000.23%
Other shareholders
EXELIXIS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Meditor Group Ltd 15,966,038$282,918,00060.81%
NEXTHERA CAPITAL LP 1,735,030$30,745,0005.89%
GREAT POINT PARTNERS LLC 2,075,000$36,769,0005.73%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 704,534$9,574,0004.55%
Matrix Capital Management Company, LP 10,000,000$177,200,0004.38%
Consonance Capital Management LP 3,879,050$68,737,0003.70%
Rhenman & Partners Asset Management AB 1,261,414$22,352,0002.24%
BB BIOTECH AG 2,785,000$49,350,0001.31%
CAPITAL MANAGEMENT CORP /VA 285,575$5,060,0001.29%
TEALWOOD ASSET MANAGEMENT INC 155,376$2,753,0001.03%
View complete list of EXELIXIS INC shareholders